This is consistent with our proposed stemness conferring and maintaining role of JARID1B, since ALDH has been demonstrated to be a marker for stem/progenitor cells in several carcinomas and its activity is suggested to be crucial for both stem cell longevity and the resistance of CSCs to chemotherapy. Here, KDM5B is linked to carcinoma.